How Decentralized Clinical Trial (DCT) Design Brings Clinical Research as a Care Option to Cancer Patients
Esther Howard, Oncology Advisor at THREAD, will be shedding light on how DCT design brings clinical research as a care option to cancer patients. In 2021, over 608,000 Americans alone passed away from cancer- equating to 1,600 deaths a day. Because clinical trials become the only treatment option for cancer patients after they have exhausted all standard of care options, we desperately need solutions to bring real access to clinical trials as a care option to more cancer patients. Esther will focus on some of the challenges that patients face, and how elements of a DCT design can not only save the lives of more patients but can also be a key driver in improving diversity in enrollment.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Accelerate Inclusive Enrollment and Delivery with Lightship
February 19th 2025
- Harmonizing Data in Clinical Research
October 21st 2024
- Parexel’s FSP: Evolving With Your Needs Now and in the Future
October 3rd 2024